Literature DB >> 20166136

Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells.

Danielle McKeithen1, Tisheeka Graham, Leland W K Chung, Valerie Odero-Marah.   

Abstract

BACKGROUND: Snail transcription factor induces epithelial-mesenchymal transition (EMT) via decreased cell adhesion-associated molecules like E-cadherin, and increased mesenchymal markers like vimentin. We previously established Snail-mediated EMT model utilizing androgen-dependent LNCaP cells. These cells express increased vimentin protein and relocalization of E-cadherin from the cell membrane to the cytosol. Interestingly, Snail transfection in LNCaP cells resulted in cells acquiring a neuroendocrine (NE)-like morphology with long neurite-like processes.
METHODS: We tested for expression of NE markers neuron-specific enolase (NSE) and chromogranin A (CgA) by Western blot analysis, and performed proliferation assays to test for paracrine cell proliferation.
RESULTS: LNCaP cells transfected with Snail displayed increase in the NE markers, NSE and CgA as well as translocation of androgen receptor (AR) to the nucleus. LNCaP C-33 cells that have been previously published as a neuroendocrine differentiation (NED) model exhibited increased expression levels of Snail protein as compared to LNCaP parental cells. Functionally, conditioned medium from the LNCaP-Snail transfected cells increased proliferation of parental LNCaP and PC-3 cells, which could be abrogated by NSE/CgA siRNA. Additionally, NED in LNCaP-C33 cells or that induced in parental LNCaP cells by serum starvation could be inhibited by knockdown of Snail with siRNA.
CONCLUSION: Overall our data provide evidence that Snail transcription factor may promote tumor aggressiveness in the LNCaP cells through multiple processes; induction of EMT may be required to promote migration, while NED may promote tumor proliferation by a paracrine mechanism. Therefore, therapeutic targeting of Snail may prove beneficial in not only abrogating EMT but also NED.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166136      PMCID: PMC2877267          DOI: 10.1002/pros.21132

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  54 in total

1.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Authors:  L Bubendorf; A Schöpfer; U Wagner; G Sauter; H Moch; N Willi; T C Gasser; M J Mihatsch
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

Review 2.  Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases.

Authors:  Martine P Roudier; Eva Corey; Lawrence D True; Celestia S Hiagno; Susan M Ott; Robert L Vessell
Journal:  Cancer Treat Res       Date:  2004

3.  The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation.

Authors:  Tadashi Ohkubo; Masayuki Ozawa
Journal:  J Cell Sci       Date:  2004-03-09       Impact factor: 5.285

4.  STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .

Authors:  M T Spiotto; T D Chung
Journal:  Prostate       Date:  2000-02-15       Impact factor: 4.104

5.  Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells.

Authors:  K Vanoverberghe; F Vanden Abeele; P Mariot; G Lepage; M Roudbaraki; J L Bonnal; B Mauroy; Y Shuba; R Skryma; N Prevarskaya
Journal:  Cell Death Differ       Date:  2004-03       Impact factor: 15.828

6.  Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.

Authors:  Daisaku Hirano; Yasuhiro Okada; Sadatsugu Minei; Yukie Takimoto; Norimichi Nemoto
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

Review 7.  The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review).

Authors:  M V Cronauer; W A Schulz; T Burchardt; A G Anastasiadis; A de la Taille; R Ackermann; M Burchardt
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

8.  NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

Authors:  Ren Jie Jin; Yongqing Wang; Naoya Masumori; Kenichiro Ishii; Taiji Tsukamoto; Scott B Shappell; Simon W Hayward; Susan Kasper; Robert J Matusik
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

9.  Snail family members and cell survival in physiological and pathological cleft palates.

Authors:  Concepción Martínez-Alvarez; María J Blanco; Raquel Pérez; M Angeles Rabadán; Marta Aparicio; Eva Resel; Tamara Martínez; M Angela Nieto
Journal:  Dev Biol       Date:  2004-01-01       Impact factor: 3.582

Review 10.  [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].

Authors:  H Bonkhoff; T Fixemer
Journal:  Urologe A       Date:  2004-07       Impact factor: 0.639

View more
  48 in total

1.  Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells.

Authors:  Petrina Barnett; Rebecca S Arnold; Roman Mezencev; Leland W K Chung; Majd Zayzafoon; Valerie Odero-Marah
Journal:  Biochem Biophys Res Commun       Date:  2010-11-17       Impact factor: 3.575

2.  Snail negatively regulates cell adhesion to extracellular matrix and integrin expression via the MAPK pathway in prostate cancer cells.

Authors:  Corey L Neal; Danielle Mckeithen; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

3.  Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells.

Authors:  Liza J Burton; Basil A Smith; Bethany N Smith; Quentin Loyd; Peri Nagappan; Danielle McKeithen; Catera L Wilder; Manu O Platt; Tamaro Hudson; Valerie A Odero-Marah
Journal:  Carcinogenesis       Date:  2015-06-10       Impact factor: 4.944

Review 4.  Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.

Authors:  Loredana Puca; Panagiotis J Vlachostergios; Himisha Beltran
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

Review 5.  The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Authors:  Rhonda L Bitting; Daneen Schaeffer; Jason A Somarelli; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

6.  Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer.

Authors:  Eunsohl Lee; Jingcheng Wang; Younghun Jung; Frank C Cackowski; Russell S Taichman
Journal:  J Cell Biochem       Date:  2018-01-09       Impact factor: 4.429

7.  CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.

Authors:  Younghun Jung; Frank C Cackowski; Kenji Yumoto; Ann M Decker; Jingcheng Wang; Jin Koo Kim; Eunsohl Lee; Yugang Wang; Jae-Seung Chung; Amy M Gursky; Paul H Krebsbach; Kenneth J Pienta; Todd M Morgan; Russell S Taichman
Journal:  Cancer Res       Date:  2018-02-05       Impact factor: 12.701

Review 8.  The role of Snail in prostate cancer.

Authors:  Bethany N Smith; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

Review 9.  The role of phenotypic plasticity in the escape of cancer cells from targeted therapy.

Authors:  Michael F Emmons; Fernanda Faião-Flores; Keiran S M Smalley
Journal:  Biochem Pharmacol       Date:  2016-06-25       Impact factor: 5.858

Review 10.  Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting.

Authors:  E S Antonarakis; A J Armstrong; S M Dehm; J Luo
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-05-17       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.